General Information of Drug Transporter (DT)
DT ID DTD0162 Transporter Info
Gene Name SLC24A1
Transporter Name Sodium/potassium/calcium exchanger 1
Gene ID
9187
UniProt ID
O60721
Epigenetic Regulations of This DT (EGR)

Methylation

  Pancretic ductal adenocarcinoma

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC24A1 in pancretic ductal adenocarcinoma [ 1 ]

Location

5'UTR (cg22374485)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:4.81E+00 Statistic Test p-value:6.75E-36; Z-score:1.84E+01

Methylation in Case

2.95E-01 (Median) Methylation in Control 6.13E-02 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC24A1 in pancretic ductal adenocarcinoma [ 1 ]

Location

TSS200 (cg19876838)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.03E+00 Statistic Test p-value:3.92E-07; Z-score:-1.23E+00

Methylation in Case

8.02E-01 (Median) Methylation in Control 8.29E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC24A1 in pancretic ductal adenocarcinoma [ 1 ]

Location

TSS200 (cg04230910)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.52E+00 Statistic Test p-value:9.43E-05; Z-score:-5.98E-01

Methylation in Case

7.57E-02 (Median) Methylation in Control 1.15E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC24A1 in pancretic ductal adenocarcinoma [ 1 ]

Location

Body (cg08831522)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.10E+00 Statistic Test p-value:9.05E-03; Z-score:7.68E-01

Methylation in Case

8.29E-01 (Median) Methylation in Control 7.56E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Bladder cancer

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC24A1 in bladder cancer [ 2 ]

Location

TSS1500 (cg00431427)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.15E+00 Statistic Test p-value:9.56E-04; Z-score:-8.20E+00

Methylation in Case

7.40E-01 (Median) Methylation in Control 8.51E-01 (Median)

Studied Phenotype

Bladder cancer[ ICD-11:2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC24A1 in bladder cancer [ 2 ]

Location

Body (cg18193482)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.21E+00 Statistic Test p-value:2.28E-05; Z-score:5.54E+00

Methylation in Case

8.93E-01 (Median) Methylation in Control 7.36E-01 (Median)

Studied Phenotype

Bladder cancer[ ICD-11:2C94]

Experimental Material

Patient tissue samples

  Breast cancer

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC24A1 in breast cancer [ 3 ]

Location

TSS1500 (cg00431427)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.06E+00 Statistic Test p-value:6.91E-08; Z-score:-1.48E+00

Methylation in Case

7.96E-01 (Median) Methylation in Control 8.46E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC24A1 in breast cancer [ 3 ]

Location

TSS1500 (cg07116160)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.03E+00 Statistic Test p-value:2.51E-02; Z-score:-7.02E-01

Methylation in Case

8.64E-01 (Median) Methylation in Control 8.89E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC24A1 in breast cancer [ 3 ]

Location

Body (cg01704999)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.11E+00 Statistic Test p-value:7.43E-05; Z-score:6.76E-01

Methylation in Case

1.09E-01 (Median) Methylation in Control 9.77E-02 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC24A1 in breast cancer [ 3 ]

Location

Body (cg18193482)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.03E+00 Statistic Test p-value:1.30E-03; Z-score:-9.57E-01

Methylation in Case

8.80E-01 (Median) Methylation in Control 9.09E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Colorectal cancer

           5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC24A1 in colorectal cancer [ 4 ]

Location

TSS1500 (cg00431427)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.07E+00 Statistic Test p-value:7.28E-09; Z-score:-3.30E+00

Methylation in Case

8.40E-01 (Median) Methylation in Control 9.00E-01 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC24A1 in colorectal cancer [ 4 ]

Location

Body (cg18193482)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.02E+00 Statistic Test p-value:6.02E-04; Z-score:9.74E-01

Methylation in Case

9.21E-01 (Median) Methylation in Control 9.04E-01 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC24A1 in colorectal cancer [ 4 ]

Location

Body (cg01704999)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.07E+00 Statistic Test p-value:1.11E-03; Z-score:5.38E-01

Methylation in Case

1.93E-01 (Median) Methylation in Control 1.81E-01 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Epigenetic regulation in BRAF-mutated CRC [ 7 ]

Location

Genome-wide

Epigenetic Type

Methylation Experiment Method Metabolomics & epigenomic profiling

Studied Phenotype

Colorectal cancer[ ICD-11:2B90]

Experimental Material

39 MSS BRAF-mutated CRC tumors

Additional Notes

SLC24A1 is implicated in the hypermethylation phenotype of microsatellite-stable BRAF-mutated CRC. Low vitamin C levels (regulated by SLC23A1) may reduce TET demethylase activity, contributing to global hypermethylation.

  Hepatocellular carcinoma

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC24A1 in hepatocellular carcinoma [ 5 ]

Location

TSS1500 (cg00431427)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.06E+00 Statistic Test p-value:5.51E-07; Z-score:-1.48E+00

Methylation in Case

7.86E-01 (Median) Methylation in Control 8.33E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC24A1 in hepatocellular carcinoma [ 5 ]

Location

TSS1500 (cg14601251)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.02E+00 Statistic Test p-value:2.95E-05; Z-score:-9.37E-01

Methylation in Case

8.45E-01 (Median) Methylation in Control 8.64E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC24A1 in hepatocellular carcinoma [ 5 ]

Location

TSS1500 (cg20330315)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.01E+00 Statistic Test p-value:4.20E-03; Z-score:-5.00E-01

Methylation in Case

8.49E-01 (Median) Methylation in Control 8.61E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Papillary thyroid cancer

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC24A1 in papillary thyroid cancer [ 6 ]

Location

TSS1500 (cg14601251)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.10E+00 Statistic Test p-value:2.19E-05; Z-score:2.18E+00

Methylation in Case

8.98E-01 (Median) Methylation in Control 8.14E-01 (Median)

Studied Phenotype

Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

Patient tissue samples

  Lymphoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Moderate hypomethylation of SLC24A1 in lymphoma than that in healthy individual

Studied Phenotype

Lymphoma [ICD-11:2B30]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value:2.23E-10; Fold-change:-0.280112254; Z-score:-1.861762716
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Esthesioneuroblastoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Significant hypomethylation of SLC24A1 in esthesioneuroblastoma than that in healthy individual

Studied Phenotype

Esthesioneuroblastoma [ICD-11:2D50.1]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value:1.71E-07; Fold-change:-0.39108765; Z-score:-2.515422902
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Medulloblastoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Significant hypomethylation of SLC24A1 in medulloblastoma than that in healthy individual

Studied Phenotype

Medulloblastoma [ICD-11:2A00.10]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value:2.08E-41; Fold-change:-0.342164428; Z-score:-1.90683029
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Multilayered rosettes embryonal tumour

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Significant hypomethylation of SLC24A1 in multilayered rosettes embryonal tumour than that in healthy individual

Studied Phenotype

Multilayered rosettes embryonal tumour [ICD-11:2A00.1]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value:6.93E-20; Fold-change:-0.44643774; Z-score:-3.110669103
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples
References
1 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
2 DNA Methylation Dynamics in Urological Tumors.
3 Genome-wide Scan for Methylation Profiles in Breast Cancer
4 Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
5 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
6 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
7 Comprehensive metabolomic and epigenomic characterization of microsatellite stable BRAF-mutated colorectal cancer. Oncogene. 2025 Jun;44(22):1718-1730.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.